Symbol="MRNA"
AssetType="Common Stock"
Name="Moderna Inc"
Description="Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1682852"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="41243001000"
EBITDA="5174000000"
PERatio="9.3"
PEGRatio="0"
BookValue="49.67"
DividendPerShare="0"
DividendYield="0"
EPS="11.63"
RevenuePerShareTTM="48.89"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="0.117"
ReturnOnEquityTTM="0.266"
RevenueTTM="15059000000"
GrossProfitTTM="10552000000"
DilutedEPSTTM="11.63"
QuarterlyEarningsGrowthYOY="-0.978"
QuarterlyRevenueGrowthYOY="-0.693"
AnalystTargetPrice="187.81"
TrailingPE="9.3"
ForwardPE="32.47"
PriceToSalesRatioTTM="3.722"
PriceToBookRatio="4.462"
EVToRevenue="3.54"
EVToEBITDA="5.34"
Beta="1.611"
num_52WeekHigh="217.25"
num_52WeekLow="107.6"
num_50DayMovingAverage="122.87"
num_200DayMovingAverage="151.43"
SharesOutstanding="381209000"
DividendDate="None"
ExDividendDate="None"
symbol="MRNA"
open="108.89"
high="111.68"
low="107.60"
price="108.19"
volume="4035010.00"
latest_trading_day="2023-08-04"
previous_close="109.95"
change="-1.76"
change_percent="-1.6007%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="3332408"
Change_recent_avg="-0.45"
Delta_recent_avg="4.59"
Variance_recent_avg="2.29"
Change_ratio_recent_avg="-0.38"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1102"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0135.jpeg"
image_negative_thumbnail_id_2="1149"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0182.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="536"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_positive_thumbnail_id_1="641"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0067.jpeg"
image_positive_thumbnail_id_2="987"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0149.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
